Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-26-032561

Chief Medical Officer sold 51,880 shares at $2.05 ($106,536)

  • Chief Medical Officer acquired 131,167 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Jones Mitchell Lawrence · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-06 Exercise or conversion : show line 1 in the form +131,167 145,889 D
2026-07-07 Sale : show line 2 in the form −51,880 $2.05 $106,536 94,009 D
Open-market sales · 51,880 sh · avg $2.05 · $106,536

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-06 Exercise or conversion : show line 3 in the form Restricted Stock Units −131,167 655,833 D
Loading xslF345X06/ownership.xml…